848 related articles for article (PubMed ID: 16079837)
1. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
3. Tumour biology: senescence in premalignant tumours.
Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
[TBL] [Abstract][Full Text] [Related]
4. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
6. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
7. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
[TBL] [Abstract][Full Text] [Related]
9. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
10. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
[TBL] [Abstract][Full Text] [Related]
11. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
12. Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts.
D'Orazi G; Soddu S; Sacchi A
Anticancer Res; 2000; 20(5B):3497-502. PubMed ID: 11131653
[TBL] [Abstract][Full Text] [Related]
13. Cancer: crime and punishment.
Sharpless NE; DePinho RA
Nature; 2005 Aug; 436(7051):636-7. PubMed ID: 16079829
[No Abstract] [Full Text] [Related]
14. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain.
Krouwels IM; Wiesmeijer K; Abraham TE; Molenaar C; Verwoerd NP; Tanke HJ; Dirks RW
J Cell Biol; 2005 Aug; 170(4):537-49. PubMed ID: 16103223
[TBL] [Abstract][Full Text] [Related]
15. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR.
Kamoi K; Yamamoto K; Misawa A; Miyake A; Ishida T; Tanaka Y; Mochizuki M; Watanabe T
Retrovirology; 2006 Jan; 3():5. PubMed ID: 16409643
[TBL] [Abstract][Full Text] [Related]
16. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
17. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
19. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
20. Normal cellular senescence and cancer susceptibility in mice genetically deficient in Ras-induced senescence-1 (Ris1).
Nieto M; Barradas M; Criado LM; Flores JM; Serrano M; Llano E
Oncogene; 2007 Mar; 26(12):1673-80. PubMed ID: 16964279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]